ArticleCancer cell international2019

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.

Marta Llaurado Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.